Learn More
Medchemexpress LLC Glesatinib hydrochloride | 2319837-80-2 | 98.01% | 656.17 | 100 MG

Supplier: Medchemexpress LLC HY19642A100MG
Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. This tyrosine kinase inhibitor also antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). It is intended for research use only and not for patient use.
- Orally active
- Potent MET/SMO dual inhibitor
- Tyrosine kinase inhibitor
- Antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.